Lundbeck will supply Russia with medicine for as long as sanctions allow

As long as Lundbeck is able to supply drugs to patients in Russia under current sanctions, the pharmaceutical firm will do so, says Chief Commercial Officer Jacob Tolstrup.

Jacob Tolstrup., Chief Commercial Officer at Lundbeck | Photo: PR / Lundbeck

Despite Russia’s invasion of neighboring country Ukraine, which has resulted in extensive sanctions against the aggressor from the Western world, Danish pharmaceutical firm Lundbeck will continue its activities there.

”As a pharmaceutical company, we believe we have an obligation to those patients who need our medications – these for example include people suffering from schizophrenia, depression and anxiety. This is also why drugs are usually exempted from sanctions,” Chief Commercial Officer at Lundbeck Jacob Tolstrup tells MedWatch, in a written comment.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs